Medicure Announces Grant of Stock Options
The Options, which vest immediately, are exercisable for a period of five years and have been granted in accordance with the terms of the Company's current stock option plan.
- The Options, which vest immediately, are exercisable for a period of five years and have been granted in accordance with the terms of the Company's current stock option plan.
- The grant of Options is subject to the approval of the TSX Venture Exchange.
- Medicure is a pharmaceutical company focused on the development and commercialization of therapies for the U.S. cardiovascular market.
- To learn more about The Extended Supply Generic Drug Program call 800.286.6781 or email [email protected] .For more information on Medicure please visit www.medicure.com .